Showing 2,662 results

Filters Content type: News, Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

New & experimental hepatitis C treatment

Sector Snap: Hepatitis C drug developers rise

Editor's pick
Bloomberg Business Week
18 October 2011
Treatment guidelines

New European HIV treatment guidelines expand treatment recommendations but anticipate possible drug shortages

News
18 October 2011
Harm reduction

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence

Editor's pick
Drug and Alcohol Findings
18 October 2011
Hepatitis C treatment

People on methadone can succeed on hepatitis C treatment

News
18 October 2011
New & experimental hepatitis C treatment

Roche buys Anadys for $230 million to boost hep C business

Editor's pick
PharmaTimes
18 October 2011
Hepatitis C treatment

Gene variant that helps hepatitis C treatment may hinder HIV treatment

News
14 October 2011
Adherence

Hepatitis C Medication Adherence Is an Important Challenge, Study Shows

Editor's pick
AIDSMeds
13 October 2011
Adherence

Copy of Hepatitis C Medication Adherence Is an Important Challenge, Study Shows

Editor's pick
Kaiser Daily Global Health Policy Report
13 October 2011
New & experimental hepatitis C treatment

Transgene Says 3 Patients in Hepatitis Trial Had Blood Disorders

Editor's pick
Bloomberg Business Week
12 October 2011
New & experimental hepatitis C treatment

Pharmasset again expands hepatitis C drug study

Editor's pick
Bloomberg BusinessWeek
11 October 2011
New & experimental hepatitis C treatment

Vertex's Hep C Drug Needs A Growth Injection

Editor's pick
The Street
11 October 2011
New & experimental HIV treatments

Boehringer signs away HIV rights to focus on hep C - InPharm

Editor's pick
InPharm
7 October 2011
New & experimental hepatitis C treatment

ICAAC: HCV Drug Telaprevir Shows No Problematic Interactions with Raltegravir

Editor's pick
HIVandhepatitis.com
6 October 2011
Pharmaceutical industry

Bristol-Myers Is Close To Completing A Groundbreaking Hepatitis C Treatment

Editor's pick
Business Insider
3 October 2011
New & experimental hepatitis C treatment

Vertex takes early rounds of hep C bout with Merck

Editor's pick
Reuters
3 October 2011
Hepatitis C symptoms & diagnosis

Hepatitis C in the U.S. May Be Underestimated by Over a Million

Editor's pick
AIDSMeds
30 September 2011
Hepatitis C treatment

Hepatitis C patients likely to falter in adherence to treatment regimen over time, Penn study shows

Editor's pick
Eurekalert Medicine & Health
29 September 2011
Hepatitis C treatment

Updated Hepatitis C Practice Guidelines Now Available from AASLD

Editor's pick
Market Watch (press release)
28 September 2011
New & experimental hepatitis C treatment

J&J's hep C drug Incivo approved in Europe

Editor's pick
InPharm
22 September 2011
Exposure to HIV through medical procedures

CDC Calls for Improved Transplant Screening

Editor's pick
Fox News
21 September 2011
New & experimental hepatitis C treatment

New anti-hepatitis C drug BMS-790052 does well in Phase IIa study

News
20 September 2011
Hepatitis B

Shark chemical 'a good antiviral'

Editor's pick
BBC Health
20 September 2011
Hepatitis C transmission & prevention

Hepatitis C is transmitted by unprotected sex between HIV-infected men: Ongoing epidemic in New York City in HIV-infected men

Editor's pick
Science Daily
15 September 2011
New & experimental hepatitis C treatment

Pharmasset Initiates QUANTUM, a Phase 2b Interferon-Free Trial of PSI-7977 and PSI-938 for All HCV Genotypes

Editor's pick
Pharmasset press release
14 September 2011